Benefit-risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment. [electronic resource]
Producer: 20161031Description: e009387 p. digitalISSN:- 2044-6055
- Adult
- Chemical and Drug Induced Liver Injury -- etiology
- Clinical Decision-Making
- Female
- Health Policy
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- adverse effects
- Male
- Middle Aged
- Myalgia -- chemically induced
- Myocardial Infarction -- prevention & control
- Patients
- Pharmacists
- Physician's Role
- Risk Assessment -- methods
- Stroke -- prevention & control
- Surveys and Questionnaires
- Thailand
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.